$0.5495
-0.0233-4.07%
Last update: Nov 5, 10:11 AM
Rani Therapeutics Holdings Inc
RANINASDAQ
The average analyst price target for Rani Therapeutics Hldgs is $9.18, 1570.6% above the current price. Of 8 analysts, 8 rate it Buy. Targets range from $4 to $15. The latest change came on Aug 18, 2026, when Chardan Capital initiated coverage of Rani Therapeutics Hldgs with a Buy rating and a $6 price target.
Price Target Range — 12 Quarters
Analyst Consensus — 8 Analysts
Rating Trend — Last 9 Months
